Prognostic factors and survival in elderly breast cancer patients: roles of age, stage and inflammatory markers.

However, patients aged ≥ 75 years tended to be diagnosed at more advanced stages, although this did not reach statistical significance ( p = 0.267).

also in 111,027 other papers

A significant trend toward shorter survival was observed with increasing disease stage: 211 months (95% CI, 189–NR) for stage I, 142 months (95% CI, 106–179) for stage II, 106 months (95% CI, 74–144) for stage III, and 36.5 months (95% CI, 27–57) for stage IV ( p < 0.001) (Fig. 2 B).

also in 9,775 other papers